HOUSTON (AP) — HOUSTON (AP) — Alaunos Therapeutics, Inc. (TCRT) on Wednesday reported a loss of $1.7 million in its first quarter.

On a per-share basis, the Houston-based company said it had a loss of 11 cents.

The drug developer posted revenue of $1,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TCRT at https://www.zacks.com/ap/TCRT